Skip to main content

previous disabled Page of 2
and
  1. Article

    Open Access

    IDH mutations in G2-3 conventional central bone chondrosarcoma: a mono institutional experience

    Heterozygous isocitrate dehydrogenase (IDH) mutations occur in about half of conventional central bone chondrosarcomas (CCBC). Aim of this study was to assess the frequency and prognostic impact of IDH mutations ...

    Elisabetta Setola, S. Benini, A. Righi, G. Gamberi, E. Carretta, C. Ferrari in BMC Cancer (2023)

  2. Article

    Open Access

    Pathobiological implications of the d16HER2 splice variant for stemness and aggressiveness of HER2-positive breast cancer

    We have previously shown that the d16HER2 splice variant is linked to HER2-positive breast cancer (BC) tumorigenesis, progression and response to Trastuzumab. However, the mechanisms by which d16HER2 contribut...

    L Castagnoli, G C Ghedini, A Koschorke, T Triulzi, M Dugo, P Gasparini in Oncogene (2017)

  3. No Access

    Article

    CD99 suppresses osteosarcoma cell migration through inhibition of ROCK2 activity

    CD99, a transmembrane protein encoded by MIC2 gene is involved in multiple cellular events including cell adhesion and migration, apoptosis, cell differentiation and regulation of protein trafficking either in ph...

    C Zucchini, M C Manara, R S Pinca, P De Sanctis, C Guerzoni, M Sciandra in Oncogene (2014)

  4. Article

    Open Access

    Human responses against HER-2-positive cancer cells in human immune system-engrafted mice

    Human immune system (HIS)-engrafted mice are new tools to investigate human immune responses. Here, we used HIS mice to study human immune responses against human HER-2-positive cancer cells and their ability ...

    C De Giovanni, G Nicoletti, L Landuzzi, F Romani, S Croci in British Journal of Cancer (2012)

  5. No Access

    Article

    Efficacy of and resistance to anti-IGF-1R therapies in Ewing's sarcoma is dependent on insulin receptor signaling

    Identification of patient selection criteria and understanding of the potential mechanisms involved in the development of resistance are crucial for an appropriate and successful design of clinical trials with...

    C Garofalo, M C Manara, G Nicoletti, M T Marino, P-L Lollini, A Astolfi in Oncogene (2011)

  6. Article

    Open Access

    Advances in preclinical therapeutics development using small animal imaging and molecular analyses: the gastrointestinal stromal tumors model

    The large use of target therapies in the treatment of gastrointestinal stromal tumors (GISTs) highlighted the urgency to integrate new molecular imaging technologies, to develop new criteria for tumor response...

    M. A. Pantaleo, L. Landuzzi, G. Nicoletti, C. Nanni in Clinical and Experimental Medicine (2009)

  7. No Access

    Article

    CD99 isoforms dictate opposite functions in tumour malignancy and metastases by activating or repressing c-Src kinase activity

    CD99 gene encodes two distinct proteins, produced by alternative splicing of CD99 gene transcript. Full-length CD99 isoform (CD99wt) is formed by an extracellular domain, followed by a transmembrane domain and a ...

    K Scotlandi, M Zuntini, M C Manara, M Sciandra, A Rocchi, S Benini, G Nicoletti in Oncogene (2007)

  8. No Access

    Article

    PET detection of epidermal growth factor receptor in colorectal cancer: a real predictor of response to cetuximab treatment?

    M. A. Pantaleo, S. Fanti, P. L. Lollini in European Journal of Nuclear Medicine and M… (2007)

  9. No Access

    Chapter and Conference Paper

    Genetic Algorithm Against Cancer

    We present an evolutionary approach to the search for effective vaccination schedules using mathematical computerized model as a fitness evaluator. Our study is based on our previous model that simulates the C...

    F. Pappalardo, E. Mastriani, P. -L. Lollini, S. Motta in Fuzzy Logic and Applications (2006)

  10. No Access

    Chapter and Conference Paper

    Model Deconstruction of an Immunoprevention Vaccine

    We present a further step in develo** an in silico model that simulates the immune system responses to tumor cells in vaccinated mice. Our study is based on our previous model that simulates the cancer – immune...

    F. Pappalardo, P. -L. Lollini, S. Motta, E. Mastriani in Advances in Natural Computation (2006)

  11. No Access

    Article

    Therapy of lung metastases through combined vaccination with carcinoma cells engineered to release IL-13 and IFN-γ

    TS/A spontaneous mouse mammary adenocarcinoma cells were engineered to release interferon-γ (IFN-γ), a Th1 cytokine (TS/A-IFNγ) and interleukin-13 (IL-13), a Th2 cytokine (TS/A-IL13). Mice bearing lung micrometas...

    C De Giovanni, G Nicoletti, L Landuzzi, I Rossi, A Astolfi, C Ricci in Gene Therapy (2001)

  12. No Access

    Chapter

    Strategies for Enhancing Tumor Immunogenicity (or how to transform a tumor cell in a Frankenstenian APC)

    The immunological approach to cancer therapy springs from the observation that the onset and growth of a tumor are events so strictly connected with immune reactivity as to be markedly influenced by it. Signif...

    F. Cavallo, P. Nanni, P. Dellabona, P. L. Lollini, G. Casorati, G. Forni in Gene Therapy (1999)

  13. No Access

    Article

    Wild-type p53-mediated down-modulation of interleukin 15 and interleukin 15 receptors in human rhabdomyosarcoma cells

    We recently reported that rhabdomyosarcoma cell lines express and secrete interleukin 15 (IL-15), a tightly regulated cytokine with IL-2-like activity. To test whether the p53-impaired function that is frequen...

    C De Giovanni, P Nanni, A Sacchi, S Soddu, I Manni, G D'Orazi in British Journal of Cancer (1998)

  14. No Access

    Article

    Therapy of murine mammary carcinoma metastasis with interferon γ and MHC gene-transduced tumour cells

    Gene-transfected tumour cells were used to cure mice bearing lung metastases by the parental, non-transduced mammary adenocarcinoma (TSA-pc). Repeated subcutaneous (s.c.) administrations of mitomycin C (MitC)-...

    P Nanni, C De Giovanni, L Landuzzi, G Nicoletti, F Frabetti in British Journal of Cancer (1996)

  15. No Access

    Article

    Redundancy of autocrine loops in human rhabdomyosarcoma cells: induction of differentiation by suramin

    Three human rhabdomyosarcoma cell lines were used to investigate the presence of autocrine loops based on the production of insulin-like growth factor (IGF)-II, basic fibroblast growth factor (bFGF) and epider...

    C De Giovanni, C Melani, P Nanni, L Landuzzi, G Nicoletti in British Journal of Cancer (1995)

  16. No Access

    Article

    Decreased adhesion to endothelial cells and matrix proteins of H-2Kb gene transfected tumour cells

    Transfection of murine metastatic B78H1 cells (derived from B16 melanoma) with a syngeneic H-2Kb gene was used to study the effect of Major Histocompatibility Complex (MHC) gene products on tumour cell adhesio...

    D Lauri, C De Giovanni, T Biondelli, E Lalli, L Landuzzi in British Journal of Cancer (1993)

  17. No Access

    Article

    Uncoupling of growth inhibition and differentiation in dexamethasone-treated human rhabdomyosarcoma cells

    The effects of dexamethasone, a synthetic glucocorticoid, and of N,N-dimethylformamide on in vitro growth and differentiation and on proto-oncogene expression of human rhabdomyosarcoma cells were studied. RD/1...

    C De Giovanni, P-L Lollini, R Dolcetti, L Landuzzi in British Journal of Cancer (1993)

  18. No Access

    Article

    Control of H-2 expression in transformed nonhaemopoietic cells by autocrine interferon

    The relationship between autocrine interferon (IFN) production and the expression of class I Major Histocompatibility Complex (MHC) membrane glycoproteins in vitro was investigated in a panel of murine transfo...

    P Nanni, L Landuzzi, G Nicoletti, C De Giovanni, M Giovarelli in British Journal of Cancer (1992)

  19. No Access

    Article

    Induction of myogenic differentiation in human rhabdomyosarcoma cells by ionising radiation, N,N-dimethylformamide and their combination

    Differentiation-inducing ability of gamma-radiation, N,N-dimethylformamide and their combination has been tested on human rhabdomyosarcoma RMZ-RC2 clone cells. Ionising radiation at 2-5 Gy doses induced a more...

    G Nicoletti, C De Giovanni, L Landuzzi, G Simone, P Rocchi in British Journal of Cancer (1992)

  20. No Access

    Article

    In vitro differentiation of rhabdomyosarcomas induced by nickel or by Moloney murine sarcoma virus

    In vitro cultures and clonal derivatives have been established from rat rhabdomyosarcomas induced by Moloney-Murine Sarcoma Virus (MSV) or by nickel sulfide; differentiation ability has been studied as express...

    P Nanni, G Azzarello, L Tessarollo, C De Giovanni, P-L Lollini in British Journal of Cancer (1991)

previous disabled Page of 2